Denali Therapeutics INC.
At a glance
Employees100-499
In business sinceNot reported
HeadquartersSouth San Francisco, CA
US patents51
SAM.gov UEIWPDGJCK93HY6
CAGE code81T85
Incorporated inDE
LEI549300ZTQ2HO18L3Q830
- TransportVehicle™ platform
- investigational therapies
- neurodegenerative diseases
- lysosomal storage disorders
- clinical study process
- clinical studies
- Early Access Program
Named on the company’s own website, read JUL 29, 2026
CareersCareers page — seen SEP 8, 2026
Supplier designations
For Profit OrganizationManufacturer of Goods
Self-certified by the company in its SAM.gov registration
Patents
51 US patents granted 2017–2025, 39 of them in the five years to SEP 2025.
Pharmaceuticals 26Organic fine chemistry 18Measurement 7
- Fusion proteins comprising acid alpha-glucosidase enzymes and methods thereofUS 12,378,540 · granted AUG 5, 2025
- Compounds, compositions and methodsUS 12,358,928 · granted JUL 15, 2025
- LRRK2 inhibitors and methods of making and using thereofUS 12,358,896 · granted JUL 15, 2025
- Anti-TREM2 antibodies and methods of use thereofUS 12,240,902 · granted MAR 4, 2025
- Compounds, compositions and methodsUS 12,180,211 · granted DEC 31, 2024
Newest 5 shown · Granted to Denali Therapeutics INC. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Denali Therapeutics INC. | South San Francisco | CA | 100–499 | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.